CoCr Coronary Stent
Outstanding Clinical Results
Exceptionally Low TLR (Target Lesion Revascularization): 2.5% at 6 months
NIRxcell was tested on over 1,000 patients and found highly-effective in numerous clinical trials
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.